Kura Oncology (KURA) Competitors $6.24 +0.04 (+0.65%) Closing price 04:00 PM EasternExtended Trading$6.45 +0.21 (+3.37%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KURA vs. AAPG, KYMR, BHVN, IBRX, HRMY, TWST, BLTE, KNSA, ARWR, and CGONShould you be buying Kura Oncology stock or one of its competitors? The main competitors of Kura Oncology include Ascentage Pharma Group International (AAPG), Kymera Therapeutics (KYMR), Biohaven (BHVN), ImmunityBio (IBRX), Harmony Biosciences (HRMY), Twist Bioscience (TWST), Belite Bio (BLTE), Kiniksa Pharmaceuticals (KNSA), Arrowhead Pharmaceuticals (ARWR), and CG Oncology (CGON). These companies are all part of the "pharmaceutical products" industry. Kura Oncology vs. Ascentage Pharma Group International Kymera Therapeutics Biohaven ImmunityBio Harmony Biosciences Twist Bioscience Belite Bio Kiniksa Pharmaceuticals Arrowhead Pharmaceuticals CG Oncology Kura Oncology (NASDAQ:KURA) and Ascentage Pharma Group International (NASDAQ:AAPG) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Do analysts rate KURA or AAPG? Kura Oncology presently has a consensus target price of $24.50, indicating a potential upside of 293.01%. Given Kura Oncology's higher possible upside, equities analysts clearly believe Kura Oncology is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kura Oncology 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.93Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in KURA or AAPG? Kura Oncology received 439 more outperform votes than Ascentage Pharma Group International when rated by MarketBeat users. However, 100.00% of users gave Ascentage Pharma Group International an outperform vote while only 69.73% of users gave Kura Oncology an outperform vote. CompanyUnderperformOutperformKura OncologyOutperform Votes44069.73% Underperform Votes19130.27% Ascentage Pharma Group InternationalOutperform Votes1100.00% Underperform VotesNo Votes Which has stronger valuation & earnings, KURA or AAPG? Ascentage Pharma Group International has higher revenue and earnings than Kura Oncology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKura Oncology$67.99M7.94-$152.63M-$2.10-2.97Ascentage Pharma Group International$980.65M2.26N/AN/AN/A Does the media prefer KURA or AAPG? In the previous week, Kura Oncology had 18 more articles in the media than Ascentage Pharma Group International. MarketBeat recorded 18 mentions for Kura Oncology and 0 mentions for Ascentage Pharma Group International. Ascentage Pharma Group International's average media sentiment score of 1.16 beat Kura Oncology's score of 0.53 indicating that Ascentage Pharma Group International is being referred to more favorably in the news media. Company Overall Sentiment Kura Oncology Positive Ascentage Pharma Group International Positive Is KURA or AAPG more profitable? Ascentage Pharma Group International's return on equity of 0.00% beat Kura Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Kura OncologyN/A -44.09% -39.57% Ascentage Pharma Group International N/A N/A N/A SummaryKura Oncology and Ascentage Pharma Group International tied by winning 6 of the 12 factors compared between the two stocks. Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KURA vs. The Competition Export to ExcelMetricKura OncologyPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$537.98M$6.47B$5.32B$8.44BDividend YieldN/A2.64%5.21%4.11%P/E Ratio-2.639.0726.8119.78Price / Sales7.94255.02387.95118.50Price / CashN/A65.8538.2534.62Price / Book1.176.436.774.52Net Income-$152.63M$143.98M$3.23B$248.32M7 Day Performance4.77%2.34%1.73%0.58%1 Month Performance-1.20%4.47%10.92%13.09%1 Year Performance-72.35%-2.70%17.16%7.74% Kura Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KURAKura Oncology4.3095 of 5 stars$6.24+0.6%$24.50+292.6%-72.0%$540.23M$67.99M-2.64130Analyst ForecastAnalyst RevisionAAPGAscentage Pharma Group InternationalN/A$24.20-0.5%N/AN/A$2.11B$980.65M0.00600News CoveragePositive NewsGap DownKYMRKymera Therapeutics2.7461 of 5 stars$32.17+7.0%$55.53+72.6%-14.7%$2.09B$47.07M-13.75170Positive NewsAnalyst ForecastBHVNBiohaven3.46 of 5 stars$20.47+1.1%$62.54+205.5%-59.4%$2.09BN/A-2.19239Analyst DowngradeIBRXImmunityBio1.8449 of 5 stars$2.36+14.0%$12.19+416.4%-61.1%$2.08B$14.75M-2.57590Analyst UpgradeHigh Trading VolumeHRMYHarmony Biosciences4.7828 of 5 stars$35.65+4.7%$52.33+46.8%+16.4%$2.05B$744.85M16.90200Positive NewsTWSTTwist Bioscience4.2833 of 5 stars$32.95+6.9%$50.40+53.0%-35.4%$1.97B$347.68M-9.75990Positive NewsBLTEBelite Bio2.0509 of 5 stars$61.99+1.5%$96.67+55.9%+48.2%$1.97BN/A-55.8510News CoverageAnalyst DowngradeAnalyst RevisionKNSAKiniksa Pharmaceuticals2.9152 of 5 stars$26.84+3.1%$38.80+44.6%+34.8%$1.95B$481.17M-191.70220Insider TradeARWRArrowhead Pharmaceuticals3.517 of 5 stars$13.97+7.2%$41.44+196.7%-38.8%$1.92B$2.50M-2.70400News CoverageAnalyst ForecastAnalyst RevisionCGONCG Oncology2.2204 of 5 stars$25.16+6.0%$57.70+129.3%-9.5%$1.92B$1.14M-17.7261Analyst Forecast Related Companies and Tools Related Companies AAPG Alternatives KYMR Alternatives BHVN Alternatives IBRX Alternatives HRMY Alternatives TWST Alternatives BLTE Alternatives KNSA Alternatives ARWR Alternatives CGON Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KURA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KURA Stock Free KURA Stock Alerts